The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers

The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers

Recently, we reported the involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness. This study assessed the human TOR signaling regulator (TIPRL)/microtubule-associated light chain 3 (LC3)/prominin-1 (CD133)/cluster of differentiation 44 (CD44) as potential diagnostic and prognostic biomarkers...

Full description

Bibliographic Details
Main Authors: Soo Young Jun, Hyang Ran Yoon, Ji-Yong Yoon, Su-Jin Jeon, Jeong-Ju Lee, Debasish Halder, Jin-Man Kim, Nam-Soon Kim
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
liver cancer
human TOR signaling regulator (TIPRL)
microtubule-associated light chain 3 (LC3)
prominin-1 (CD133)
cluster of differentiation 44 (CD44)
receiver-operating characteristic (ROC) curve
Online Access:https://www.mdpi.com/2072-6694/13/12/2925

Internet

https://www.mdpi.com/2072-6694/13/12/2925

Similar Items